| Year |
Citation |
Score |
| Low-probability matches (unlikely to be authored by this person) |
| 2016 |
Asensio-Lopez MC, Lax A, Sanchez-Mas J, Avellaneda A, Planes J, Pascual-Figal DA. Reformulated meat products protect against ischemia-induced cardiac damage Food and Function. 7: 992-1001. DOI: 10.1039/c5fo01189b |
0.01 |
|
| 2015 |
Navas-Carretero S, San-Cristobal R, Avellaneda A, Planes J, Zulet MA, Martínez JA. Benefits on body fat composition of isocalorically controlled diets including functionally optimized meat products: Role of alpha-linolenic acid Journal of Functional Foods. 12: 319-331. DOI: 10.1016/j.jff.2014.12.005 |
0.01 |
|
| 2014 |
Castro E, Avellaneda A, Marco P. Combination of advanced oxidation processes and biological treatment for the removal of benzidine-derived dyes Environmental Progress and Sustainable Energy. 33: 873-885. DOI: 10.1002/ep.11865 |
0.01 |
|
| 2013 |
Avellaneda A, Valente P, Burgun A, Evans JD, Markwell-Heys AW, Rankine D, Nielsen DJ, Hill MR, Sumby CJ, Doonan CJ. Kinetically controlled porosity in a robust organic cage material. Angewandte Chemie (International Ed. in English). 52: 3746-9. PMID 23427022 DOI: 10.1002/Anie.201209922 |
0.01 |
|
| 2013 |
Liang MK, Li LT, Avellaneda A, Moffett JM, Hicks SC, Awad SS. Outcomes and predictors of incisional surgical site infection in stoma reversal. Jama Surgery. 148: 183-9. PMID 23426597 DOI: 10.1001/Jamasurgery.2013.411 |
0.01 |
|
| 2012 |
Rankine D, Avellaneda A, Hill MR, Doonan CJ, Sumby CJ. Control of framework interpenetration for in situ modified hydroxyl functionalised IRMOFs. Chemical Communications (Cambridge, England). 48: 10328-30. PMID 22971691 DOI: 10.1039/C2Cc35565E |
0.01 |
|
| 2012 |
Fraser TN, Avellaneda AA, Graviss EA, Musher DM. Acute kidney injury associated with trimethoprim/sulfamethoxazole. The Journal of Antimicrobial Chemotherapy. 67: 1271-7. PMID 22351681 DOI: 10.1093/jac/dks030 |
0.01 |
|
| 2012 |
Avellaneda A, Hollis CA, He X, Sumby CJ. Fluorescent hexaaryl- and hexa-heteroaryl[3]-radialenes: Synthesis, structures, and properties Beilstein Journal of Organic Chemistry. 8: 71-80. DOI: 10.3762/bjoc.8.7 |
0.01 |
|
| 2010 |
Fernà ndez-Lopez L, Rifà B, Pujol F, Becerra J, Pérez M, Meroño M, Zaragoza K, Rafel A, DÃaz O, Avellaneda A, Casado MJ, Giménez A, Casabona J. Impact of the introduction of rapid HIV testing in the Voluntary Counselling and Testing sites network of Catalonia, Spain. International Journal of Std & Aids. 21: 388-91. PMID 20606218 DOI: 10.1258/ijsa.2008.008459 |
0.01 |
|
| 2010 |
Avellaneda AS, Pérez MEG, Font-Mayolas S. Alcohol consumption patterns in adolescence Psicothema. 22: 189-195. PMID 20423620 |
0.01 |
|
| 2007 |
Avellaneda A, Izquierdo M, Torrent-Farnell J, Ramón JR. Rare Diseases: Chronic diseases that need a new approach Anales Del Sistema Sanitario De Navarra. 30: 177-190. PMID 17898813 |
0.01 |
|
| 2004 |
Delmas F, Avellaneda A, Di Giorgio C, Robin M, De Clercq E, Timon-David P, Galy JP. Synthesis and antileishmanial activity of (1,3-benzothiazol-2-yl) amino-9-(10H)-acridinone derivatives European Journal of Medicinal Chemistry. 39: 685-690. PMID 15276301 DOI: 10.1016/j.ejmech.2004.04.006 |
0.01 |
|
| 2003 |
Avellaneda A. We love Julio very much: Political sayings of Argentine literature Explicacion De Textos Literarios. 32: 62-71. |
0.01 |
|
| 2002 |
Avellaneda A, Robin M, Faure R, Périchaud A, Galy JP. 1H and 13C chemical shifts for acridines: Part XVII. (1,3-Benzothiazol-2-yl)amino-9(10H)-acridinone derivatives Magnetic Resonance in Chemistry. 40: 545-548. DOI: 10.1002/mrc.1049 |
0.01 |
|
| 1999 |
Gómez-Gerique JA, Gutiérrez-Fuentes JA, Montoya MT, Porres A, Rueda A, Avellaneda A, Rubio MA. The lipid profile of Spanish population: The DRECE Study (Diet and Risk of Cardiovascular Disease in Spain) Medicina Clinica. 113: 730-735. |
0.01 |
|
| 1999 |
De Stefano H, González B, Boada-Sucre A, Avellaneda A, Godoy S, Soto H. Effect of Trypanosoma vivax Infection on Semen Quality of Siboney Bull Revista Cientifica De La Facultad De Ciencias Veterinarias De La Universidad Del Zulia. 9: 411-417. |
0.01 |
|
| 1997 |
Gutiérrez JA, Rueda A, Avellaneda A. [Current treatment of hyperlipoproteinemia]. Anales De Medicina Interna (Madrid, Spain : 1984). 14: 38-46. PMID 9091035 |
0.01 |
|
| 1996 |
Lozano P, Avellaneda A, Pascual R, Iborra JL. Stability of immobilized α-chymotrypsin in supercritical carbon dioxide Biotechnology Letters. 18: 1345-1350. DOI: 10.1007/BF00129968 |
0.01 |
|
| 1996 |
Lozano P, Avellaneda A, Iborra JL. Peptide synthesis by papain in alkali halide media Biocatalysis and Biotransformation. 13: 255-269. |
0.01 |
|
| 1993 |
Avellaneda A, Rueda A, Cascio C, Gutiérrez JA. [Changes in the lipid profiles of hyperlipemic patients treated with binifibrate]. Anales De Medicina Interna (Madrid, Spain : 1984). 10: 275-9. PMID 8334204 |
0.01 |
|
| 1991 |
Anez MS, Martinez D, Pacheco JL, Gonzalez GH, Rivera J, Pelaschier E, Uzcategui L, Romero MD, Molina Z, Roditti de Montilla M, Avellaneda A. Indomethacin in the treatment of acute cholecystitis and biliary colic Gen. 45: 32-37. PMID 1843681 |
0.01 |
|
| 1991 |
Fereira-Valbuena H, Fernández de Argüello E, Campos G, Ryder E, Avellaneda A. Serum concentration of calcium and calcitonin in hyperthyroidism caused by Graves' disease Investigacion Clinica. 32: 109-114. PMID 1814473 |
0.01 |
|
| Hide low-probability matches. |